» Articles » PMID: 30008669

Screening for Mutations in a Chinese Amyotrophic Lateral Sclerosis Cohort

Overview
Specialty Geriatrics
Date 2018 Jul 17
PMID 30008669
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Previous research has identified mutations in familial (FALS) and sporadic amyotrophic lateral sclerosis (SALS), as well as in frontotemporal dementia (FTD). The aim of our study was to measure the frequency of mutations in a Chinese population. In total, 78 FALS patients, 581 SALS patients and 584 controls were included. We found 19 missense mutations, nine synonymous mutations and two intron variants. According to the American College of Medical Genetics and Genomics (ACMG) standards and guidelines for the interpretation of sequence variants, eight variants were judged to be pathogenic or likely pathogenic variants. The frequency of such variants was 2.56% in FALS and 1.03% in SALS. In conclusion, mutations are common in FALS and SALS patients of Chinese origin, and further study is still needed.

Citing Articles

Exploring the Role of Variants in Italian ALS Patients.

Bisogni G, Conte A, Costantino U, Lattante S, Bernardo D, Lucioli G Genes (Basel). 2025; 15(12.

PMID: 39766833 PMC: 11727902. DOI: 10.3390/genes15121566.


The E3 Ubiquitin Ligase SCF Cyclin F Promotes Sequestosome-1/p62 Insolubility and Foci Formation and is Dysregulated in ALS and FTD Pathogenesis.

Davidson J, Wu S, Rayner S, Cheng F, Duncan K, Russo C Mol Neurobiol. 2023; 60(9):5034-5054.

PMID: 37243816 PMC: 10415446. DOI: 10.1007/s12035-023-03355-2.


Genetic and clinical analysis of gene in amyotrophic lateral sclerosis patients from Chinese mainland.

Tang X, Yuan Y, Liu Z, Bu Y, Tang L, Zhao Q Front Aging Neurosci. 2023; 15:1114022.

PMID: 36845660 PMC: 9947132. DOI: 10.3389/fnagi.2023.1114022.


ALS-linked loss of Cyclin-F function affects HSP90.

Siebert A, Gattringer V, Weishaupt J, Behrends C Life Sci Alliance. 2022; 5(12).

PMID: 36114006 PMC: 9481933. DOI: 10.26508/lsa.202101359.

References
1.
Rowland L, Shneider N . Amyotrophic lateral sclerosis. N Engl J Med. 2001; 344(22):1688-700. DOI: 10.1056/NEJM200105313442207. View

2.
Brooks B, Miller R, Swash M, Munsat T . El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2001; 1(5):293-9. DOI: 10.1080/146608200300079536. View

3.
Kaufmann P, Levy G, Thompson J, Delbene M, Battista V, Gordon P . The ALSFRSr predicts survival time in an ALS clinic population. Neurology. 2005; 64(1):38-43. DOI: 10.1212/01.WNL.0000148648.38313.64. View

4.
Kimura F, Fujimura C, Ishida S, Nakajima H, Furutama D, Uehara H . Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology. 2006; 66(2):265-7. DOI: 10.1212/01.wnl.0000194316.91908.8a. View

5.
Neumann M, Sampathu D, Kwong L, Truax A, Micsenyi M, Chou T . Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006; 314(5796):130-3. DOI: 10.1126/science.1134108. View